v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   80,020,131      
Balance at beginning of period at Dec. 31, 2024 $ 3,298   $ 397,673 $ 6,361 $ (400,736)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss (4,601)     110 (4,711)
Issued pursuant to restricted share unit awards (in shares)   1,098,511      
Issued pursuant to at-the-market offering agreements, net of issuance cost (in shares)   5,302,950      
Issued pursuant to at-the-market offering agreements, net of issuance costs 4,183   4,183    
Stock-based compensation expense 845   845    
Balance at end of period (in shares) at Mar. 31, 2025   86,421,592      
Balance at end of period at Mar. 31, 2025 3,725   402,701 6,471 (405,447)
Balance at beginning of period (in shares) at Dec. 31, 2024   80,020,131      
Balance at beginning of period at Dec. 31, 2024 3,298   397,673 6,361 (400,736)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss (9,911)        
Balance at end of period (in shares) at Jun. 30, 2025   97,407,903      
Balance at end of period at Jun. 30, 2025 3,699   407,985 6,438 (410,724)
Balance at beginning of period (in shares) at Mar. 31, 2025   86,421,592      
Balance at beginning of period at Mar. 31, 2025 3,725   402,701 6,471 (405,447)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss (5,310)     (33) (5,277)
Issued pursuant to restricted share unit awards (in shares)   158,135      
Issue pursuant to SEPA Arrangement (in shares)   7,562,152      
Issue pursuant to SEPA Arrangement 3,176   3,176    
Issued pursuant to at-the-market offering agreements, net of issuance cost (in shares)   3,266,024      
Issued pursuant to at-the-market offering agreements, net of issuance costs 1,746   1,746    
Stock-based compensation expense 362   362    
Balance at end of period (in shares) at Jun. 30, 2025   97,407,903      
Balance at end of period at Jun. 30, 2025 $ 3,699   407,985 6,438 (410,724)
Balance at beginning of period (in shares) at Dec. 31, 2025 108,021,271 108,021,271      
Balance at beginning of period at Dec. 31, 2025 $ (3,799)   419,471 6,225 (429,495)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss (9,243)       (9,243)
Issued pursuant to restricted share unit awards (in shares)   10,317      
Issued pursuant to at-the-market offering agreements, net of issuance cost (in shares)   7,446,574      
Issued pursuant to at-the-market offering agreements, net of issuance costs 7,614   7,614    
Issued pursuant to consulting services agreements (in shares)   650,000      
Issued pursuant to consulting service agreements 539   539    
Reclassification of warrants 77   77    
Stock option liability reclassification (1,189)   (1,189)    
Stock-based compensation expense 871   871    
Balance at end of period (in shares) at Mar. 31, 2026   116,128,162      
Balance at end of period at Mar. 31, 2026 $ (5,130)   427,383 6,225 (438,738)
Balance at beginning of period (in shares) at Dec. 31, 2025 108,021,271 108,021,271      
Balance at beginning of period at Dec. 31, 2025 $ (3,799)   419,471 6,225 (429,495)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss $ (18,685)        
Issued pursuant to consulting services agreements (in shares) 1,300,000        
Issued pursuant to consulting service agreements $ 1,161        
Balance at end of period (in shares) at Jun. 30, 2026 124,637,521 124,637,521      
Balance at end of period at Jun. 30, 2026 $ (6,167)   435,788 6,225 (448,180)
Balance at beginning of period (in shares) at Mar. 31, 2026   116,128,162      
Balance at beginning of period at Mar. 31, 2026 (5,130)   427,383 6,225 (438,738)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss and other comprehensive loss (9,442)       (9,442)
Issued pursuant to at-the-market offering agreements, net of issuance cost (in shares)   7,859,359      
Issued pursuant to at-the-market offering agreements, net of issuance costs $ 6,771   6,771    
Issued pursuant to consulting services agreements (in shares) 650,000 650,000      
Issued pursuant to consulting service agreements $ 622   622    
Stock-based compensation expense $ 1,012   1,012    
Balance at end of period (in shares) at Jun. 30, 2026 124,637,521 124,637,521      
Balance at end of period at Jun. 30, 2026 $ (6,167)   $ 435,788 $ 6,225 $ (448,180)